Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry

Journal of Proteome Research

Volumn 12, Issue 9, 2013, Pages 3865-3873

  Pasikanti, Kishore Kumar ^a   Esuvaranathan, Kesavan ^b   Hong, Yanjun ^a   Ho, Paul C ^a   Mahendran, Ratha ^b   Raman Nee Mani, Lata ^b   Chiong, Edmund ^b   Chan, Eric Chun Yong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

bladder cancer; GC GC TOFMS; metabolomics; metabonomics; metabotyping; two dimensional gas chromatography

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; 3 HYDROXYANTHRANILIC ACID; 3 HYDROXYKYNURENINE; ANTHRANILIC ACID; BIOLOGICAL MARKER; CITRIC ACID; CREATININE; CRESOL; KYNURENIC ACID; KYNURENINE; PSEUDOURIDINE; PYRUVIC ACID DERIVATIVE; QUINOLINIC ACID; TRYPTOPHAN; TUMOR MARKER; URIDINE; VANILMANDELIC ACID; XANTHURENIC ACID;

ADULT; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CHEMOMETRIC ANALYSIS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GAS CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; MALE; METABOLITE; METABOLOMICS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TIME OF FLIGHT MASS SPECTROMETRY; TRYPTOPHAN METABOLISM; TWO DIMENSIONAL GAS CHROMATOGRAPHY TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS; URINARY METABOTYPING; URINE LEVEL; VALIDATION PROCESS;

AGED; CASE-CONTROL STUDIES; CREATININE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; TRYPTOPHAN; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84883815567     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr4000448     Document Type: Article

References (49)

1. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010 Ca-Cancer J. Clin. 2010, 60 (5) 277-300
2. Mitra, A. P.; Cote, R. J. Molecular screening for bladder cancer: progress and potential Nat. Rev. Urol. 2010, 7 (1) 11-20
3. Lokeshwar, V. B.; Habuchi, T.; Grossman, H. B.; Murphy, W. M.; Hautmann, S. H.; Hemstreet, G. P., 3rd; Bono, A. V.; Getzenberg, R. H.; Goebell, P.; Schmitz-Drager, B. J.; Schalken, J. A.; Fradet, Y.; Marberger, M.; Messing, E.; Droller, M. J. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers Urology 2005, 66 (6 Suppl 1) 35-63
4. Mariotto, A. B.; Yabroff, K. R.; Shao, Y.; Feuer, E. J.; Brown, M. L. Projections of the cost of cancer care in the United States: 2010-2020 J. Natl. Cancer Inst. 2011, 103 (2) 117-28
5. Wadhwa, N.; Jatawa, S. K.; Tiwari, A. Non-invasive urine based tests for the detection of bladder cancer J. Clin. Pathol. 2012, 65 (11) 970-5
6. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29 (11) 1181-9
7. Fiehn, O. Metabolomics - the link between genotypes and phenotypes Plant Mol. Biol. 2002, 48 (1-2) 155-71
8. Kaddurah-Daouk, R.; Kristal, B. S.; Weinshilboum, R. M. Metabolomics: A global biochemical approach to drug response and disease Annu. Rev. Pharmacol. Toxicol. 2008, 48, 653-83
9. Martin, F. P.; Dumas, M. E.; Wang, Y.; Legido-Quigley, C.; Yap, I. K.; Tang, H.; Zirah, S.; Murphy, G. M.; Cloarec, O.; Lindon, J. C.; Sprenger, N.; Fay, L. B.; Kochhar, S.; van Bladeren, P.; Holmes, E.; Nicholson, J. K. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model Mol. Syst. Biol. 2007, 3, 112
10. Hood, L.; Heath, J. R.; Phelps, M. E.; Lin, B. Systems biology and new technologies enable predictive and preventative medicine Science 2004, 306 (5696) 640-3
11. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009, 457 (7231) 910-4
12. Spratlin, J. L.; Serkova, N. J.; Eckhardt, S. G. Clinical applications of metabolomics in oncology: A review Clin. Cancer Res. 2009, 15 (2) 431-40
13. Pasikanti, K. K.; Esuvaranathan, K.; Ho, P. C.; Mahendran, R.; Kamaraj, R.; Wu, Q. H.; Chiong, E.; Chan, E. C. Noninvasive urinary metabonomic diagnosis of human bladder cancer J. Proteome Res. 2010, 9 (6) 2988-95
14. Keun, H. C. Metabonomic modeling of drug toxicity Pharmacol. Ther. 2006, 109 (1-2) 92-106
15. Chan, E. C.; Pasikanti, K. K.; Nicholson, J. K. Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry Nat. Protoc. 2011, 6 (10) 1483-99
16. Issaq, H. J.; Nativ, O.; Waybright, T.; Luke, B.; Veenstra, T. D.; Issaq, E. J.; Kravstov, A.; Mullerad, M. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry J. Urol. 2008, 179 (6) 2422-6
17. Putluri, N.; Shojaie, A.; Vasu, V. T.; Vareed, S. K.; Nalluri, S.; Putluri, V.; Thangjam, G. S.; Panzitt, K.; Tallman, C. T.; Butler, C.; Sana, T. R.; Fischer, S. M.; Sica, G.; Brat, D. J.; Shi, H.; Palapattu, G. S.; Lotan, Y.; Weizer, A. Z.; Terris, M. K.; Shariat, S. F.; Michailidis, G.; Sreekumar, A. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression Cancer Res. 2011, 71 (24) 7376-86
18. Srivastava, S.; Roy, R.; Singh, S.; Kumar, P.; Dalela, D.; Sankhwar, S. N.; Goel, A.; Sonkar, A. A. Taurine-a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by 1H NMR spectroscopy Cancer Biomarkers 2010, 6 (1) 11-20
19. Xiayan, L.; Legido-Quigley, C. Advances in separation science applied to metabonomics Electrophoresis 2008, 29 (18) 3724-36
20. Griffin, J. L. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos. Trans. R. Soc. London, Ser. B: Biol. Sci. 2006, 361 (1465) 147-61
21. Mondello, L.; Tranchida, P. Q.; Dugo, P.; Dugo, G. Comprehensive two-dimensional gas chromatography-mass spectrometry: A review Mass Spectrom. Rev. 2008, 27 (2) 101-24
22. Li, X.; Xu, Z.; Lu, X.; Yang, X.; Yin, P.; Kong, H.; Yu, Y.; Xu, G. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus Anal. Chim. Acta 2009, 633 (2) 257-62
23. Mohler, R. E.; Dombek, K. M.; Hoggard, J. C.; Pierce, K. M.; Young, E. T.; Synovec, R. E. Comprehensive analysis of yeast metabolite GC × GC-TOFMS data: combining discovery-mode and deconvolution chemometric software Analyst 2007, 132 (8) 756-67
24. Shellie, R. A.; Welthagen, W.; Zrostlikova, J.; Spranger, J.; Ristow, M.; Fiehn, O.; Zimmermann, R. Statistical methods for comparing comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry results: metabolomic analysis of mouse tissue extracts J. Chromatogr. A 2005, 1086 (1-2) 83-90
25. Cortes, H. J.; Winniford, B.; Luong, J.; Pursch, M. Comprehensive two dimensional gas chromatography review J. Sep. Sci. 2009, 32 (5-6) 883-904
26. Ong, R. C.; Marriott, P. J. A review of basic concepts in comprehensive two-dimensional gas chromatography J. Chromatogr. Sci. 2002, 40 (5) 276-91
27. Pierce, K. M.; Hoggard, J. C.; Mohler, R. E.; Synovec, R. E. Recent advancements in comprehensive two-dimensional separations with chemometrics J. Chromatogr. A 2008, 1184 (1-2) 341-52
28. Mal, M.; Koh, P. K.; Cheah, P. Y.; Chan, E. C. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry Anal. Bioanal. Chem 2012, 403 (2) 483-93
29. Epstein, J. I.; Amin, M. B.; Reuter, V. R.; Mostofi, F. K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee Am. J. Surg. Pathol. 1998, 22 (12) 1435-48
30. Kopka, J.; Schauer, N.; Krueger, S.; Birkemeyer, C.; Usadel, B.; Bergmuller, E.; Dormann, P.; Weckwerth, W.; Gibon, Y.; Stitt, M.; Willmitzer, L.; Fernie, A. R.; Steinhauser, D. GMD@CSB.DB: The Golm Metabolome Database Bioinformatics 2005, 21 (8) 1635-8
31. Wishart, D. S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A. C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; Fung, C.; Nikolai, L.; Lewis, M.; Coutouly, M. A.; Forsythe, I.; Tang, P.; Shrivastava, S.; Jeroncic, K.; Stothard, P.; Amegbey, G.; Block, D.; Hau, D. D.; Wagner, J.; Miniaci, J.; Clements, M.; Gebremedhin, M.; Guo, N.; Zhang, Y.; Duggan, G. E.; Macinnis, G. D.; Weljie, A. M.; Dowlatabadi, R.; Bamforth, F.; Clive, D.; Greiner, R.; Li, L.; Marrie, T.; Sykes, B. D.; Vogel, H. J.; Querengesser, L. HMDB: The Human Metabolome Database Nucleic Acids Res. 2007, 35 (Database issue) D521-6
32. Mendes, P. Emerging bioinformatics for the metabolome Briefings Bioinf. 2002, 3 (2) 134-45
33. Oh, C.; Huang, X.; Regnier, F. E.; Buck, C.; Zhang, X. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry peak sorting algorithm J. Chromatogr. A 2008, 1179 (2) 205-15
34. Koh, Y.; Pasikanti, K. K.; Yap, C. W.; Chan, E. C. Comparative evaluation of software for retention time alignment of gas chromatography/time-of-flight mass spectrometry-based metabonomic data J. Chromatogr. A 2010, 1217 (52) 8308-16
35. Sangster, T.; Major, H.; Plumb, R.; Wilson, A. J.; Wilson, I. D. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis Analyst 2006, 131 (10) 1075-8
36. Bryan, G. T. The role of urinary tryptophan metabolites in the etiology of bladder cancer Am. J. Clin. Nutr. 1971, 24 (7) 841-7
37. Sidransky, H. Tryptophan and carcinogenesis: review and update on how tryptophan may act Nutr. Cancer 1997, 29 (3) 181-94
38. Opitz, C. A.; Litzenburger, U. M.; Sahm, F.; Ott, M.; Tritschler, I.; Trump, S.; Schumacher, T.; Jestaedt, L.; Schrenk, D.; Weller, M.; Jugold, M.; Guillemin, G. J.; Miller, C. L.; Lutz, C.; Radlwimmer, B.; Lehmann, I.; von Deimling, A.; Wick, W.; Platten, M. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 2011, 478 (7368) 197-203
39. Bone, E.; Tamm, A.; Hill, M. The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer Am. J. Clin. Nutr. 1976, 29 (12) 1448-54
40. Sanders, J. M.; Bucher, J. R.; Peckham, J. C.; Kissling, G. E.; Hejtmancik, M. R.; Chhabra, R. S. Carcinogenesis studies of cresols in rats and mice Toxicology 2009, 257 (1-2) 33-9
41. Lawrie, C. A.; Renwick, A. G.; Sims, J. The urinary excretion of bacterial amino-acid metabolites by rats fed saccharin in the diet Food Chem. Toxicol. 1985, 23 (4-5) 445-50
42. Onuki, T.; Yamagishi, T.; Teranishi, J.; Suzuki, K.; Kondo, K.; Nakaigawa, N.; Saito, K.; Noguchi, K.; Kubota, Y. Clinical study of 38 cases of pheochromocytoma - correlation between the instability of intraoperative blood pressure and 24-h urinary vanillylmandelic acid Hinyokika Kiyo 2007, 53 (7) 449-54
43. Shono, T.; Sakai, H.; Minami, Y.; Suzu, H.; Kanetake, H.; Saito, Y. Paraganglioma of the urinary bladder: A case report and review of the Japanese literature Urol. Int. 1999, 62 (2) 102-5
44. Usuda, H.; Emura, I. Composite paraganglioma-ganglioneuroma of the urinary bladder Pathol. Int. 2005, 55 (9) 596-601
45. Panichi, S.; Dell'Anna, G.; Innocenti, P.; Nesi, G. Paraganglioma of the bladder: report of a case Ann. Ital. Chir. 1999, 70 (6) 937-9 discussion 940.
46. Kvist, E.; Sjolin, K. E.; Iversen, J.; Nyholm, K. Urinary excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the urinary bladder Scand. J. Urol. Nephrol. 1993, 27 (1) 45-53
47. Nyholm, K. K.; Sjolin, K. E.; Hammer, M.; Knudsen, J.; Stahl, D.; Nielsen, H. R. A study on the clinical significance of urinary beta-aminoisobutyric acid in patients with urothelial tumours Biomedicine 1975, 22 (6) 509-16
48. Guneral, F.; Bachmann, C. Age-related reference values for urinary organic acids in a healthy Turkish pediatric population Clin. Chem. 1994, 40 (6) 862-6
49. Clayton, T. A.; Baker, D.; Lindon, J. C.; Everett, J. R.; Nicholson, J. K. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (34) 14728-33